Clinical Trial Update: Aminopterin in Treating Patients With Refractory Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating aminopterin in patients with refractory leukemia has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• Aminopterin (Aminopterin)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Leukemia | Phase 2 | Status: COMPLETED